BIOMAT Database Logo BIOMAT Database Logo

Heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids as leukotriene biosynthesis inhibitors. 2000

T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Immunoscience Research, Abbott Laboratories, D47K, AP10, 100 Abbott Park Road, Abbott Park, Illinois 600064, USA. teodozyj.kolasa@abbott.com

A novel series of heteroarylmethoxyphenylalkoxyiminoalkylcarboxylic acids was studied as leukotriene biosynthesis inhibitors. A hypothesis of structure-activity optimization by insertion of an oxime moiety was investigated using REV-5901 as a starting point. A systematic structure-activity optimization showed that the spatial arrangement and stereochemistry of the oxime insertion unit proved to be important for inhibitory activity. The promising lead, S-(E)-11, inhibited LTB(4) biosynthesis in the intact human neutrophil with IC(50) of 8 nM and had superior oral activity in vivo, in a rat pleurisy model (ED(50) = 0.14 mg/kg) and rat anaphylaxis model (ED(50) = 0.13 mg/kg). In a model of lung inflammation, S-(E)-11 blocked LTE(4) biosynthesis (ED(50) of 0.1 mg/kg) and eosinophil influx (ED(50) of 0.2 mg/kg). S-(E)-11 (A-93178) was selected for further preclinical evaluation.

UI MeSH Term Description Entries
D007975 Leukotriene B4 The major metabolite in neutrophil polymorphonuclear leukocytes. It stimulates polymorphonuclear cell function (degranulation, formation of oxygen-centered free radicals, arachidonic acid release, and metabolism). (From Dictionary of Prostaglandins and Related Compounds, 1990) 5,12-HETE,5,12-diHETE,LTB4,Leukotriene B,Leukotriene B-4,Leukotrienes B,5,12 HETE,5,12 diHETE,B-4, Leukotriene,Leukotriene B 4
D008297 Male Males
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D011001 Pleuropneumonia Inflammation of the lung parenchyma that is associated with PLEURISY, inflammation of the PLEURA. Pleuropneumonias
D011014 Pneumonia Infection of the lung often accompanied by inflammation. Experimental Lung Inflammation,Lobar Pneumonia,Lung Inflammation,Pneumonia, Lobar,Pneumonitis,Pulmonary Inflammation,Experimental Lung Inflammations,Inflammation, Experimental Lung,Inflammation, Lung,Inflammation, Pulmonary,Inflammations, Lung,Inflammations, Pulmonary,Lobar Pneumonias,Lung Inflammation, Experimental,Lung Inflammations,Lung Inflammations, Experimental,Pneumonias,Pneumonias, Lobar,Pneumonitides,Pulmonary Inflammations
D011804 Quinolines
D006099 Granuloma A relatively small nodular inflammatory lesion containing grouped mononuclear phagocytes, caused by infectious and noninfectious agents. Granulomas
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000180 Acrylic Resins Polymers of high molecular weight which are derived from acrylic acid, methacrylic acid or other related compounds and are capable of being molded and then hardened to form useful components. Acrylic Resin,Resin, Acrylic,Resins, Acrylic
D000707 Anaphylaxis An acute hypersensitivity reaction due to exposure to a previously encountered ANTIGEN. The reaction may include rapidly progressing URTICARIA, respiratory distress, vascular collapse, systemic SHOCK, and death. Anaphylactic Reaction,Anaphylactoid Reaction,Anaphylactoid Shock,Shock, Anaphylactic,Anaphylactic Reactions,Anaphylactic Shock,Anaphylactoid Reactions,Reaction, Anaphylactic,Reaction, Anaphylactoid,Shock, Anaphylactoid

Related Publications

T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Leukotriene biosynthesis inhibitors.
November 1985, Pharmaceutical research,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Synthesis of indolylalkoxyiminoalkylcarboxylates as leukotriene biosynthesis inhibitors.
March 1997, Bioorganic & medicinal chemistry,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Leukotriene antagonists and inhibitors of leukotriene biosynthesis as potential therapeutic agents.
January 1991, Progress in drug research. Fortschritte der Arzneimittelforschung. Progres des recherches pharmaceutiques,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Medicinal plants from nepal: evaluation as inhibitors of leukotriene biosynthesis.
June 2000, Journal of ethnopharmacology,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Novel leukotriene biosynthesis inhibitors (2012-2016) as anti-inflammatory agents.
May 2017, Expert opinion on therapeutic patents,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Amino hydroxamic acids as potent inhibitors of leukotriene A4 hydrolase.
October 1995, Bioorganic & medicinal chemistry,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
2,3-Dihydro-5-benzofuranols as antioxidant-based inhibitors of leukotriene biosynthesis.
May 1989, Journal of medicinal chemistry,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Antiallergic action of inhibitors of leukotriene biosynthesis.
January 1985, Advances in prostaglandin, thromboxane, and leukotriene research,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Inhibitors of amino acids biosynthesis as antifungal agents.
February 2015, Amino acids,
T Kolasa, and D E Gunn, and P Bhatia, and K W Woods, and T Gane, and A O Stewart, and J B Bouska, and R R Harris, and K I Hulkower, and P E Malo, and R L Bell, and G W Carter, and C D Brooks
Orally active hydroxamic acid inhibitors of leukotriene biosynthesis.
January 1988, Journal of medicinal chemistry,
Copied contents to your clipboard!